The cost of new cancer drugs continue to rise.
For some cancer patients, taking a new cancer drug is simply a matter of buying time.
It turns out, though, they are paying a lot for those extra months and years.
A study published today in JAMA Oncology reports that new cancer drugs taken in pill form have become dramatically more expensive in their initial year on the market than other drugs launched 15 years ago.
In addition, the researchers say, the prices of those drugs increase rapidly even after their first year on the market.
Dr. Alan Venook, an oncologist at the University of California, San Francisco, notes that many of these drugs are not even cures. They simply delay the progression of cancer.
“It’s beyond me. I guess they do it [raise prices] because they can do it,” Venook told Healthline. “It’s a big, big problem.”
Read Full Article: Cancer Drug Prices Still Rapidly Rising
|Read Full Article: Cancer Drug Prices Still Rapidly Rising|